Milekic's morning could be an advertisement for the potential of AI to transform health care. Mount Sinai is among a group of elite hospitals pouring hundreds of millions of dollars into AI software and education, turning their institutions into laboratories for this technology. They're buoyed by a growing body of scientific literature, such as a recent study finding AI readings of mammograms detected 20 percent more cases of breast cancer than radiologists -- along with the conviction that AI is the future of medicine.

In many health systems around the world, running a hospital is a knife-edge balancing act. On one side are the doctors and nurses providing urgent, even critical care to patients. Their job is to do all they can. On the other side are the hospital administrators making sure there are enough resources – medicines, equipment, beds, staff – to cope. Their job is to ensure spending on patient care stays efficient so that the hospital can stay open.

Chief Marketing Officer at Interactions, a conversational AI company, where he oversees all aspects of communications, sales and marketing. They say necessity is the mother of invention -- and the last year is Exhibit A. Amid the turbulence of the pandemic, we've seen impressive innovation across the board -- from the rise of grocery store robots to artificial intelligence-powered contact centers. But perhaps nowhere has this innovation been more pronounced than in the healthcare industry. Faced with unparalleled strain, medical facilities forged a new way of operating -- and artificial intelligence (AI) was front and center. From AI-powered thermal scanners to disinfection robots and autonomous PPE deliveries, AI played a central role in supporting medical staff, maintaining a sanitary environment and supporting efforts to reduce the spread of Covid-19.

IT IS a nice coincidence that IBM's greatest boss and Sherlock Holmes's sidekick shared a surname. But whether it was Thomas J. or Dr John H. who inspired the name of the firm's latest venture into artificial intelligence (AI), the association of that name with a touch of genius makes "Watson" a clever choice. This sense of cleverness was reinforced in 2011, when Watson won a specially staged version of an American TV quiz show called "Jeopardy!" The system's capacity to parse questions posed to it in the show's convoluted, pun-ridden English, to search huge natural-language databases for clues, to synthesise those clues into answers and to frame those answers in a conversational way was able to beat to the draw the finest minds of American quizdom. Winning game-show prizes, though, is not a good enough business model to justify the investment it takes to build such a system.

Artificial Intelligence (AI) is already being used in advanced medical settings and it has multiple applications including, wearable technology, precision medicine and virtual clinics. In some cases, it can even interpret test results more accurately than physicians. While most of us are just beginning to realise the full potential of AI, some entrepreneurs are way ahead. But how can they build trust with investors, what are the barriers for European startups and how can smaller companies get ahead? Pascal Lardier, VP for International Events and Media Content at HIMSS moderated the session around'AI Beyond the Buzz' at the HIMSS & Health 2.0 European Digital Conference, with the panel consisting of Neha Tanna, Investment Partner, Joyance Partners, Jorge Juan Fernández García, Director of Innovation, EIT Health, and Piotr Orzechowski, Founder & CEO, Infermedica in Poland.

Artificial intelligence is searching for the drugs to combat Covid-19. It enabled the pandemic to be tracked and information about it to be synthesised. It is diagnosing patients, triaging them, and identifying those in need of intensive care before their condition deteriorates. There is much hype about the use of artificial intelligence (AI) to combat coronavirus. Some of it is justified.

The covid-19 pandemic has shown us how much health care is in need of not just tweaking but radical change. The pressure on global health systems, providers, and staff has already been increasing to unsustainable levels. But it also illustrates how much can be achieved in times of crisis: for example, China and the UK recently built thousands of extra beds in intensive care units, or ICUs, in less than two weeks. Health-care reform will need to spur a totally different approach to how care is organized, delivered, and distributed, which will be paramount in a (hopefully soon) post-covid-19 era. It's the only way to deliver the quadruple aim of health care: better outcomes, improved patient and staff experience, and lower cost of care.

From interpreting CT scans to diagnosing eye disease, artificial intelligence is taking on medical tasks once reserved for only highly trained medical specialists -- and in many cases outperforming its human counterparts. Now AI is starting to show up in intensive care units, where hospitals treat their sickest patients. Doctors who have used the new systems say AI may be better at responding to the vast trove of medical data collected from ICU patients -- and may help save patients who are teetering between life and death. "Critical care is essentially this interface between humans and technology," says Peter Laussen, chief of critical care medicine at Toronto's Hospital for Sick Children. "The amount of data streaming from the patient in the ICU is huge," encompassing readings of blood pressure, heartbeat, oxygen levels and other vital signs.

In June 2018, Babylon Health hosted an event in London at which it showed off its latest digital healthcare development. It had developed artificial intelligence (AI) that it claimed was "better than a doctor". Considered a world-first, the AI proved it was on par with practising clinicians by taking tests, including a set of questions from the MRCGP exam – a test that has to be taken by every GP in the UK. Scoring higher than the average score over a period of five years, the AI achieved 81% during its first sitting. The industry and media alike were abuzz with excitement.

The Japanese government is teaming up with businesses and academia to set up hospitals enhanced by artificial intelligence, seeking to allow short-handed doctors to spend more time on patient care while curbing medical spending. The government is expected to invest more than $100 million in the effort over half a decade, with a target of establishing 10 model hospitals by the end of fiscal 2022. AI will help with tasks from updating patients' charts to analyzing tests and parsing images to help with diagnoses. The effort aims to address structural challenges to health care, including the chronic lack of doctors and nurses in some areas and rising medical expenses. The initiative will also help make Japan more competitive on the world stage, giving AI development a shot in the arm and helping boost exports of medical equipment. Three ministries central to the effort -- the education, industry and health ministries -- will recruit participating companies and hospitals this month, targeting AI specialists and medical equipment makers.